Mazen Noureddin MD MHSc
Hepatology & Liver Transplantation
Transplant Hepatologist, Houston Methodist Hospital, Director Houston Research Institute
Join to view full profile
6445 Main StreetFloor 22Houston, TX 77030
Phone+1 713-441-4345
Fax+1 713-790-3089
Dr. Noureddin is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Duke School of MedicineMHSc, Master's Health Sciences in Clinical Research, 2009 - 2018
University of California (San Diego) Medical CenterFellowship, Gastroenterology, 2011 - 2013
Clinical Center at the National Institutes of HealthFellowship, Transplant Hepatology, 2009 - 2011
University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Internal Medicine, 2005 - 2008
University of Aleppo Faculty of MedicineClass of 2002
Certifications & Licensure
CA State Medical License 2007 - 2027
TX State Medical License 2022 - 2027
VA State Medical License 2008 - 2012
Awards, Honors, & Recognition
- Top Doctors Pasadena Magazine 2014-2018
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2014-2015, 2017
- CMS Meaningful Use Stage 2 Certification Outgoing Public Health Reporting from EpicCare Functionality, Epic Systems Corporation, 2014-2015, 2017
Clinical Trials
Publications & Presentations
PubMed
- Hepatology: Emerging Paradigms in MASLD, Viral Hepatitis, Cholestatic Liver Disease, Portal Hypertension and Hepatocellular Carcinoma: Summary of the First Annual Pari...Zobair M Younossi, George Papatheodoridis, Emmanuel Tsochatzis, Maria Buti, Lorenza Rimassa
Liver International. 2026-09-01 - A decade of transformation in MASLD: from nomenclature to novel therapies.Jörn M Schattenberg, Mazen Noureddin
The Lancet. Gastroenterology & Hepatology. 2026-09-01 - Neighbourhood Deprivation Is Associated With Greater Mortality in Patients With Alcohol-Associated Liver Disease.Leith Ghani, Claire S Faulkner, Majd B Aboona, Pradhan Hariharan, Pooja Rangan
Alimentary Pharmacology & Therapeutics. 2026-08-17
Journal Articles
- NASH Leading Cause of Liver Transplant in Women: Updated Analysis of Indications For Liver Transplant and Ethnic and Gender Variances.Noureddin M1,2, Vipani A3, Bresee C4, Todo T5, Kim IK5, Alkhouri N6, Setiawan VW7, Tran T8,3, Ayoub WS8,3, Lu SC8,3, Klein AS5, Sundaram V8,3, Nissen NN5., American Journal of Gastrenterology, 6/8/2018
- NASH Leading Cause of Liver Transplant in Women: Updated Analysis of Indications for Liver Transplant and Ethnic and Gender VariancesTsuyoshi Todo, Walid S Ayoub, Naim Alkhouri, Nicholas N Nissen, Vinay Sundaram, Shelly C Lu, Mazen Noureddin, Aarshi Vipani, Tram Tran, Andrew S Klein, Nature
Press Mentions
Rivus Pharmaceuticals Announces New Data from Phase 2 M-ACCEL Trial of HU6 in MASH in Late-Breaker Oral Presentation at AASLD the Liver Meeting® 2025November 7th, 2025- HistoIndex Launches AI-Powered Fibrosis Assessment Test for MASH DiagnosisAugust 20th, 2025
- HistoIndex Marks Another Step Forward with FibroSIGHT™ plus: Introducing AI-Based Quantitative Analysis in Fibrosis AssessmentAugust 11th, 2025
Other Languages
- Arabic, Farsi, Spanish
External Links
- Houston Methodist Hospitalhttps://www.houstonmethodist.org/doctor/mazen-noureddin/
- Houston Research Institute https://www.houstonresearchinstitute.com/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
